Css LLC Otonomy, Inc. Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.49 - $6.23 $53,027 - $132,674	-21,296 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.48 - $6.47 $204,032 - $379,336	-58,630 Reduced 73.36%	21,296 $138,000
Q2 2020 Aug 14, 2020	BUY	$1.87 - $3.84 $7,416 - $15,229	3,966 Added 5.22%	79,926 $289,000
Q1 2020 May 15, 2020	BUY	$1.58 - $4.06 $120,016 - $308,397	75,960 New	75,960 $150,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.